Horse-derived iPS cells
by Chris Kamel
We've talked often about induced pluripotent stem cells (iPS cells) on this blog -- the transformation of adult terminally differentiated cells into stem cells that can differentiate into various lineages -- mostly in the context of discoveries in mice and potential applications in regenerative therapy for humans. One thing mentioned less often is the use of stem cell technologies for our pets and animal companions. Anew paper published by Dr. Andras Nagy's group at Mount Sinai Hospital and the University of Toronto has established equine iPS cell lines raising the possibility of stem cell therapies for horses.
Animal derived iPS cells open some interesting avenues for veterinary medicine. Several other animals have been used to develop iPS cells including monkeys, dogs, pigs, and rabbits. Perhaps, in time, we'll be seeing new regenerative medicines for our dogs and cats based on their own reprogrammed cells. While these are not the first equine iPS cells developed, they are the first to have their pluripotency properly established. The horse also presents a potentially interesting model for human injuries to muscles, joints, and ligaments -- the types of injuries common, but difficult to treat, in these animals. With the development of equine iPS cells, the horse could become integral in pioneering new human therapies.
Also read the media release.
Comments